Merck & Co., Inc. To Participate At The Morgan Stanley Global Healthcare Conference

free biotech news Get the latest biotech news where you 

want it. Sign up for the free GenePool newsletter today!

Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, chairman and chief executive officer; Adam H. Schechter, executive vice president and president, Global Human Health; and Dr. Roy Baynes, senior vice president, Clinical Development, Merck Research Laboratories, are scheduled to participate at the Morgan Stanley Global Healthcare Conference in New York on Sept. 9, 2014 at 8:00 a.m. EDT. Investors, analysts, members of the media and the general public are invited to listen to live audio presentation of the webcasts at http://www.merck.com/investors/events-and-presentations/home.html.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC